Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Nippon India Pharma Fund(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited13.547262563491145.9129
Domestic EquitiesLupin Limited7.59163083991642.1486
Domestic EquitiesDivi's Laboratories Limited6.8973900754583.4184
Domestic EquitiesCipla Limited6.32723495054535.1976
Domestic EquitiesDr. Reddy's Laboratories Limited5.82783916074492.9554
Domestic EquitiesApollo Hospitals Enterprise Limited5.6265648795475.9236
Domestic EquitiesMedPlus Health Services Limited3.46833627277293.3742
Domestic EquitiesVijaya Diagnostic Centre Limited3.40602886684288.1055
Domestic EquitiesAjanta Pharma Limited2.9043959323245.6634
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited2.7741913226234.6534
Domestic EquitiesGland Pharma Limited2.74701320549232.3638
Domestic EquitiesSai Life Sciences Limited2.67222555745226.0301
Domestic EquitiesThyrocare Technologies Limited2.57394392120217.7174
Domestic EquitiesAurobindo Pharma Limited2.46921702630208.8616
Domestic EquitiesAbbott India Limited2.441868677206.5461
Domestic EquitiesDr. Lal Path Labs Limited2.1976609112185.8888
Domestic EquitiesAlkem Laboratories Limited2.1754323678184.0109
Domestic EquitiesNarayana Hrudayalaya Limited2.1250923911179.7469
Domestic EquitiesJB Chemicals & Pharmaceuticals Limited2.0933999649177.0678
Domestic EquitiesMankind Pharma Limited2.0158757496170.5123
Domestic EquitiesBiocon Limited1.98714219374168.0788
Domestic EquitiesIPCA Laboratories Limited1.93121124164163.3523
Domestic EquitiesPfizer Limited1.8718318249158.3289
Domestic EquitiesSuraksha Diagnostic Limited1.34833896349114.0461
Domestic EquitiesEmcure Pharmaceuticals Limited1.2377740259104.6948
Domestic EquitiesMax Healthcare Institute Limited1.2253891340103.6450
Domestic EquitiesFortis Healthcare Limited1.19951103889101.4584
Domestic EquitiesSanofi India Limited1.1945230272101.0364
Domestic EquitiesSanofi Consumer Healthcare India Limited1.177021365999.5587
Domestic EquitiesSyngene International Limited0.9814128049283.0143
Domestic EquitiesAnthem Biosciences Limited0.7943105850367.1832
Domestic EquitiesAkums Drugs and Pharmaceuticals Limited0.7630151526464.5427
Domestic EquitiesAstraZeneca Pharma India Limited0.66756256856.4614
Domestic EquitiesIndoco Remedies Limited0.5557183492447.0016
Domestic EquitiesOrchid Pharma Limited0.450745756138.1240
Domestic EquitiesConcord Biotech Limited0.187311173815.8400
Total 99.4536 8412.4653
Cash & Cash Equivalents and Net AssetsTriparty Repo0.7094 60.0059
Cash & Cash Equivalents and Net AssetsCash Margin - CCIL0.0007 0.0605
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.1637 -13.8491
Total 0.5464 46.2173
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.